Literature DB >> 2536279

Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor.

D Bagchi1, R Prasad, D K Das.   

Abstract

Captopril, an angiotensin converting enzyme (ACE) inhibitor, was hypothesized to be a potential scavenger of free radicals because of the presence of a thiol group. The scavenging action of captopril was examined against superoxide anion (O2-), hydroxyl radical (OH.), hypohalite radical (HOCL) either generated biochemically, or derived from activated polymorphonuclear leukocytes (PMN). Our results indicate that captopril is an extremely potent free radical scavenger, scavenging power being as effective as superoxide dismutase (SOD) against O2-, or dimethylthiourea against OH., but better than allopurinol against OCL. plus HOCL. Free radical scavenging action of captopril against PMN-derived free radical is equivalent to the combined effects of SOD, catalase and allopurinol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536279     DOI: 10.1016/s0006-291x(89)80175-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Clinical pharmacology and therapeutics.

Authors:  M J Kendall; R C Horton
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

2.  Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations.

Authors:  P J Shultz; L Raij
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 3.  Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope?

Authors:  J McMurray; M Chopra
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

4.  Antioxidant power of angiotensin-converting enzyme inhibitors in vitro.

Authors:  I F Benzie; B Tomlinson
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

5.  Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

Authors:  D W Cushman; F L Wang; W C Fung; G J Grover; C M Harvey; R J Scalese; S L Mitch; J M DeForrest
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

6.  Does the antiarrhythmic effect of DMPO originate from its oxygen radical trapping property or the structure of the molecule itself?

Authors:  A Tosaki; R F Haseloff; A Hellegouarch; K Schoenheit; V V Martin; D K Das; I E Blasig
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

7.  N-acetylcysteine and captopril protect DNA and cells against radiolysis by fast neutrons.

Authors:  M Spotheim-Maurizot; F Garnier; C Kieda; R Sabattier; M Charlier
Journal:  Radiat Environ Biophys       Date:  1993       Impact factor: 1.925

8.  Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta.

Authors:  S Mittra; M Singh
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

9.  Contraluminal para-aminohippurate (PAH) transport in the proximal tubule of the rat kidney. VI. Specificity: amino acids, their N-methyl-, N-acetyl- and N-benzoylderivatives; glutathione- and cysteine conjugates, di- and oligopeptides.

Authors:  K J Ullrich; G Rumrich; T Wieland; W Dekant
Journal:  Pflugers Arch       Date:  1989-12       Impact factor: 3.657

10.  Catalase and glutathione peroxidase mimics.

Authors:  Brian J Day
Journal:  Biochem Pharmacol       Date:  2008-10-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.